Browse this site's news, projects, and people highlights via any of the topics in the dropdown list or below each content description.
LMAT
This genome sequencing technology helps accelerate the comparison of genetic fragments with reference genomes and improve the accuracy of the results as compared to previous technologies.
ICML25 acceptances
LLNL researchers have posters and workshop papers accepted to the 42nd International Conference on Machine Learning on July 13–19.
Cancer drug candidate developed using supercomputing & AI blocks tumor growth without toxic side effect
A new cancer drug candidate developed by LLNL, BridgeBio Oncology Therapeutics, and the Frederick National Laboratory for Cancer Research has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect.
LLNL Deputy Director Pat Falcone receives inaugural AI Honors in Public Science Award
Organizers praised Falcone's “extraordinary leadership in driving research directions to advance science and technology at one of America's most vital research institutions.”
